Sangamo Therapeutics Spot Bonus Award Letter to Andy

Summary

Sangamo Therapeutics is awarding Andy a one-time spot bonus of $100,000 in recognition of his leadership and contributions to the company's manufacturing strategy. The bonus will be paid in four equal installments on specified dates between July 2020 and December 2021, provided Andy remains a full-time employee through each payment date. The bonus is subject to applicable taxes and withholdings.

EX-10.2 5 sgmo-20200630xex102.htm EX-10.2 Document

Dear Andy:

The Executive Leadership Team recognizes your recent contributions and the critical importance of your leadership and experience to Sangamo’s manufacturing strategy. Therefore, on behalf of Sangamo, you have been awarded a one-time Spot Bonus as of December 19, 2019 to acknowledge your accomplishments, subject to the terms and conditions set out below.

The Spot Bonus will be in the gross aggregate amount of $100,000 (subject to applicable withholdings and taxes), with 25% of such amount payable on July 1, 2020, December 1, 2020, July 1, 2021 and December 1, 2021, subject to your continued full-time employment with Sangamo through and including each payment date.

I appreciate your continued effort and dedication to Sangamo and look forward to continuing working with you. If you have any questions concerning this Spot Bonus, please contact me.

We appreciate your contributions and support as we collectively work towards transforming patients’ lives.

Sincerely,

/s/ Sandy Macrae

Sandy Macrae

Chief Executive Officer